Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 3(2H)-Pyridazinone, 6-[3-fluoro-4-(4-morpholinyl)phenyl]-4,5-dihydro-5-methyl-, (5R)- | 1630760-75-6 | 98.4% | 291.32 | 50 MG
SDP

Supplier:  Medchemexpress LLC HY13635050MG

Encompass_Preferred

BRD9500 is an orally active phosphodiesterases 3 (PDE3) inhibitor, demonstrating IC50s of 10 nM for PDE3A and 27 nM for PDE3B. This compound exhibits significant antitumor activity, primarily by inhibiting PDE3A and PDE3B, leading to cancer cell killing through the induction of PDE3A/B interactions with SFLN12.

  • Orally active PDE3 inhibitor
  • Potently inhibits PDE3A (IC50: 10 nM) and PDE3B (IC50: 27 nM)
  • Exhibits antitumor activity
  • Induces PDE3A/B interactions with SFLN12 to kill cancer cells
  • Shows an EC50 of 1 nM for SK-MEL-3 melanoma cell line viability
  • Demonstrates an EC50 of 1.6 nM for HeLa cell viability
  • Stabilizes the PDE3A-SLFN12 interaction in HeLa cells
  • Inhibits SK-MEL-3 melanoma growth in mice

Catalog No. 50-003-49678


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.